A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients
Clinical trial NCT00002390 · COMPLETED
Trial details
- NCT number
- NCT00002390
- Sponsor
- Glaxo Wellcome
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.